AmSurg Shares Rise in Value After $2.35B Sheridan Deal Announcement

Raymond James analyst John Ransom set AmSurg’s price target at $60 and upgraded his recommendation to “buy,” according to a Value Walk report.

Advertisement
Carrie Pallardy

The upgrade was made closely following AmSurg’s announcement of intention to acquire Sheridan Healthcare for $2.35 billion.

More Articles on Transactions and Valuation Issues:
4 Recent ASC Industry Acquisitions
Beloit Health System ASC Project Remains in Limbo
3 Recently Opened & Expanded Ambulatory Surgery Centers

How MultiCare added 3,200 more surgical cases in 1 year

Recommended Live Webinar on Dec 11, 2025 1:00 PM - 2:00 PM CST

Advertisement

Next Up in ASC Transactions & Valuation Issues

  • The titans of physician M&A

    A handful of major healthcare organizations are redrawing the physician landscape through aggressive acquisitions, vertical integration and high-stakes partnerships.  These…

    By: Patsy Newitt

  • Georgia hospital opens surgery center

    Cordelle, Ga.-based Crisp Regional Hospital cut the ribbon on a surgery center in Cordelle, according to a Nov. 13 report…

    By: Cameron Cortigiano
Advertisement

Comments are closed.